saplin

LIC MF Healthcare Fund

LIC MF Healthcare Fund (Direct, Growth): saplin Score 5.6/10 (Weak) among 14 Sectoral/Thematic funds. 3Y return 21.8% a year vs 21.9% category median, expense ratio 1.42%. Returns that beat most peers, but higher costs than most peers. NAV ₹38.51 on 11 Nov 2026.

Loading the full analysis…

Questions about LIC MF Healthcare Fund

What is the expense ratio of LIC MF Healthcare Fund?

The Direct plan's total expense ratio is 1.42% a year, against a median of 1.04% for sectoral/thematic funds. The Regular plan costs more because it pays a distributor's commission.

Who manages LIC MF Healthcare Fund?

Sudhanshu Asthana (since 7 Apr 2026); Dhaval Sangoi (since 1 Sept 2026).

What are the top holdings of LIC MF Healthcare Fund?

Sun Pharmaceutical Industries 8.65%, Divi's Laboratories 7.09%, Apollo Hospitals Enterprise 6.13%, Torrent Pharmaceuticals 5.97%, Neuland Laboratories 5.83% of the portfolio, as of 31 Oct 2026.

What returns has LIC MF Healthcare Fund given?

1 year: 18.1% (category median 21.9%); 3 years: 21.8% a year (category median 21.9%). Past returns do not predict future ones.

How big is LIC MF Healthcare Fund?

About ₹99 cr (AMFI's average for the latest quarter).

How does LIC MF Healthcare Fund score?

5.6 out of 10 (Weak) on the saplin Score, which rates a fund against its own category on returns, risk, consistency, cost and its manager. See the methodology for how it is worked out.

More on LIC MF Healthcare